Advertisement
YOU ARE HERE: LAT HomeCollectionsViacell Inc
IN THE NEWS

Viacell Inc

FEATURED ARTICLES
BUSINESS
January 1, 2004 | From Bloomberg News
Amgen Inc. of Thousand Oaks said Wednesday that it would buy a $20-million stake in stem cell researcher ViaCell Inc. ViaCell in turn canceled its initial public offering, which had been scheduled for Wednesday. The agreement expands an earlier accord between ViaCell and Amgen, the world's biggest biotechnology company. Boston-based ViaCell says it is responsible for early development of drugs created through the partnership.
ARTICLES BY DATE
BUSINESS
January 1, 2004 | From Bloomberg News
Amgen Inc. of Thousand Oaks said Wednesday that it would buy a $20-million stake in stem cell researcher ViaCell Inc. ViaCell in turn canceled its initial public offering, which had been scheduled for Wednesday. The agreement expands an earlier accord between ViaCell and Amgen, the world's biggest biotechnology company. Boston-based ViaCell says it is responsible for early development of drugs created through the partnership.
Advertisement
NATIONAL
December 22, 2004 | David Willman, Times Staff Writer
In January 2003, Dr. Harvey G. Klein helped ring the opening bell at the New York Stock Exchange. He was joined by his fellow board members of Haemonetics Corp., a Massachusetts company that markets blood-filtering equipment. A color photo of Klein and the directors at the exchange's lectern, smiling with upraised thumbs, was published in the company's annual report.
Los Angeles Times Articles
|